Triple-negative breast cancer (TNBC) is an aggressive breast cancer negative for progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor receptor 2 (Her-2). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.